RedHill Biopharma (RDHL) Competitors $2.15 -0.05 (-2.27%) Closing price 05/1/2025 04:00 PM EasternExtended Trading$2.15 0.00 (0.00%) As of 09:02 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock RDHL vs. PRPH, INAB, IPA, CLDI, TXMD, GOVX, MBRX, TRIB, CLRB, and ABPShould you be buying RedHill Biopharma stock or one of its competitors? The main competitors of RedHill Biopharma include ProPhase Labs (PRPH), IN8bio (INAB), ImmunoPrecise Antibodies (IPA), Calidi Biotherapeutics (CLDI), TherapeuticsMD (TXMD), GeoVax Labs (GOVX), Moleculin Biotech (MBRX), Trinity Biotech (TRIB), Cellectar Biosciences (CLRB), and Abpro (ABP). These companies are all part of the "pharmaceutical products" industry. RedHill Biopharma vs. ProPhase Labs IN8bio ImmunoPrecise Antibodies Calidi Biotherapeutics TherapeuticsMD GeoVax Labs Moleculin Biotech Trinity Biotech Cellectar Biosciences Abpro RedHill Biopharma (NASDAQ:RDHL) and ProPhase Labs (NASDAQ:PRPH) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, community ranking, risk, dividends, earnings, valuation, media sentiment, profitability and analyst recommendations. Is RDHL or PRPH more profitable? RedHill Biopharma has a net margin of 0.00% compared to ProPhase Labs' net margin of -217.64%. RedHill Biopharma's return on equity of 0.00% beat ProPhase Labs' return on equity.Company Net Margins Return on Equity Return on Assets RedHill BiopharmaN/A N/A N/A ProPhase Labs -217.64%-62.92%-30.22% Does the media favor RDHL or PRPH? In the previous week, RedHill Biopharma had 2 more articles in the media than ProPhase Labs. MarketBeat recorded 3 mentions for RedHill Biopharma and 1 mentions for ProPhase Labs. ProPhase Labs' average media sentiment score of 1.89 beat RedHill Biopharma's score of 0.93 indicating that ProPhase Labs is being referred to more favorably in the news media. Company Overall Sentiment RedHill Biopharma Positive ProPhase Labs Very Positive Which has preferable valuation and earnings, RDHL or PRPH? RedHill Biopharma has higher revenue and earnings than ProPhase Labs. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioRedHill Biopharma$8.04M0.47$23.92MN/AN/AProPhase Labs$6.77M2.00-$16.78M-$1.26-0.26 Do insiders and institutionals have more ownership in RDHL or PRPH? 7.2% of RedHill Biopharma shares are held by institutional investors. Comparatively, 9.4% of ProPhase Labs shares are held by institutional investors. 6.8% of RedHill Biopharma shares are held by insiders. Comparatively, 20.7% of ProPhase Labs shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Does the MarketBeat Community believe in RDHL or PRPH? RedHill Biopharma received 313 more outperform votes than ProPhase Labs when rated by MarketBeat users. Likewise, 65.90% of users gave RedHill Biopharma an outperform vote while only 48.93% of users gave ProPhase Labs an outperform vote. CompanyUnderperformOutperformRedHill BiopharmaOutperform Votes42765.90% Underperform Votes22134.10% ProPhase LabsOutperform Votes11448.93% Underperform Votes11951.07% Which has more volatility & risk, RDHL or PRPH? RedHill Biopharma has a beta of 4.44, indicating that its stock price is 344% more volatile than the S&P 500. Comparatively, ProPhase Labs has a beta of -0.56, indicating that its stock price is 156% less volatile than the S&P 500. SummaryRedHill Biopharma beats ProPhase Labs on 9 of the 13 factors compared between the two stocks. Get RedHill Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for RDHL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RDHL vs. The Competition Export to ExcelMetricRedHill BiopharmaPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.90M$6.85B$5.54B$7.93BDividend YieldN/A2.96%5.09%4.23%P/E RatioN/A7.3222.5818.55Price / Sales0.47241.43401.13103.29Price / Cash0.0165.8538.1834.62Price / Book0.056.486.774.25Net Income$23.92M$143.41M$3.22B$248.18M7 Day Performance-10.79%1.92%1.10%0.91%1 Month Performance-12.24%4.29%2.49%2.59%1 Year Performance-99.24%-3.87%15.76%4.02% RedHill Biopharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RDHLRedHill Biopharma1.0724 of 5 stars$2.15-2.3%N/A-99.2%$3.90M$8.04M0.00210Analyst ForecastGap DownPRPHProPhase Labs1.0334 of 5 stars$0.35-5.0%N/A-93.8%$14.67M$6.77M-0.28130Upcoming EarningsPositive NewsGap DownINABIN8bio3.6072 of 5 stars$0.18-6.0%$6.00+3,270.8%-83.7%$14.46MN/A-0.2420Upcoming EarningsGap UpIPAImmunoPrecise Antibodies2.8528 of 5 stars$0.46+2.4%$4.00+768.4%-62.7%$14.31M$24.00M-0.5980Short Interest ↓Positive NewsGap UpCLDICalidi Biotherapeutics2.002 of 5 stars$0.48-0.3%$15.00+3,014.0%N/A$14.12M$50,000.000.0038Gap DownTXMDTherapeuticsMD1.766 of 5 stars$1.22+6.1%N/A-26.1%$14.12M$1.76M0.00420Upcoming EarningsAnalyst ForecastGOVXGeoVax Labs2.9607 of 5 stars$1.02+4.4%$12.90+1,164.7%-33.2%$14.12M$3.95M-0.1810Earnings ReportNews CoveragePositive NewsMBRXMoleculin Biotech2.9459 of 5 stars$0.99-6.9%$6.00+508.1%-79.6%$13.81MN/A0.0020Upcoming EarningsShort Interest ↓TRIBTrinity Biotech1.6652 of 5 stars$0.76+7.3%N/A-54.6%$13.72M$59.13M-0.34480Analyst ForecastShort Interest ↓Positive NewsGap UpCLRBCellectar Biosciences1.7408 of 5 stars$0.30-4.4%$12.50+4,117.3%-91.6%$13.66MN/A-0.1710Gap UpABPAbproN/A$0.26-18.0%$4.00+1,434.3%N/A$13.61M$183,000.000.0015Gap UpHigh Trading Volume Related Companies and Tools Related Companies ProPhase Labs Competitors IN8bio Competitors ImmunoPrecise Antibodies Competitors Calidi Biotherapeutics Competitors TherapeuticsMD Competitors GeoVax Labs Competitors Moleculin Biotech Competitors Trinity Biotech Competitors Cellectar Biosciences Competitors Abpro Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:RDHL) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersHere’s How to Claim Your Stake in Elon’s Private Company, xAII predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredTrump Orders 'National Digital Asset Stockpile'Billionaires Rush Into Digital Banking Token Three massive forces are converging right now, creating what c...Crypto 101 Media | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | SponsoredFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding RedHill Biopharma Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share RedHill Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy RDHL Stock Free RDHL Stock Alerts